Brown Financial Advisors Has $473,000 Holdings in Cardinal Health, Inc. (NYSE:CAH)

Brown Financial Advisors trimmed its stake in Cardinal Health, Inc. (NYSE:CAH) by 12.3% during the fourth quarter, Holdings Channel reports. The fund owned 4,003 shares of the company’s stock after selling 562 shares during the quarter. Brown Financial Advisors’ holdings in Cardinal Health were worth $473,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CAH. Assenagon Asset Management S.A. raised its holdings in Cardinal Health by 5.2% in the 3rd quarter. Assenagon Asset Management S.A. now owns 10,930 shares of the company’s stock valued at $1,208,000 after acquiring an additional 545 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Cardinal Health by 21.5% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,049 shares of the company’s stock valued at $2,640,000 after purchasing an additional 4,253 shares in the last quarter. Forsta AP Fonden grew its stake in shares of Cardinal Health by 2.9% in the 3rd quarter. Forsta AP Fonden now owns 108,700 shares of the company’s stock valued at $12,014,000 after purchasing an additional 3,100 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Cardinal Health by 93.6% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 46,065 shares of the company’s stock worth $5,091,000 after buying an additional 22,267 shares in the last quarter. Finally, State of Alaska Department of Revenue lifted its position in shares of Cardinal Health by 3.5% during the 3rd quarter. State of Alaska Department of Revenue now owns 57,506 shares of the company’s stock worth $6,354,000 after buying an additional 1,920 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $127.43 on Tuesday. The company has a 50 day moving average of $123.84 and a 200-day moving average of $117.53. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $132.84. The stock has a market cap of $30.78 billion, a price-to-earnings ratio of 23.77, a P/E/G ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 37.69%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CAH. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective for the company in a research note on Tuesday, January 7th. StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Argus set a $148.00 price objective on shares of Cardinal Health in a research note on Tuesday, February 4th. Jefferies Financial Group upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Finally, Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and increased their price target for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Four research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $138.40.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.